CD4 and neoplasm: In 2017, Spitzer et al. reported that a unique TH1-like CD4+ subset was expanded in non-tumour peripheral tissues during an active anti-tumour response to adjuvant therapy [42], in a study conducted in the Py-MMTV mouse model of spontaneous mammary tumours.